Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Aug;16(8):1155-61.
doi: 10.1016/j.bbmt.2010.02.024. Epub 2010 Mar 1.

Decreased infections in recipients of unrelated donor hematopoietic cell transplantation from donors with an activating KIR genotype

Marcie Tomblyn  1 , Jo-Anne H Young, Michael D Haagenson, John P Klein, Elizabeth A Trachtenberg, Jan Storek, Stephen R Spellman, Sarah Cooley, Jeffrey S Miller, Daniel J Weisdorf; CIBMTR Infection and Immune Reconstitution Working Committee
Affiliations

Decreased infections in recipients of unrelated donor hematopoietic cell transplantation from donors with an activating KIR genotype

Marcie Tomblyn et al. Biol Blood Marrow Transplant. 2010 Aug.

Abstract

Infectious complications following allogeneic hematopoietic cell transplantation (HCT) from unrelated donors (URD) result in significant morbidity. We hypothesized that recipients of a URD with an activating natural killer cell immunoglobulin-like receptor (KIR) (B/x) genotype would have decreased infectious complications because of enhanced natural killer (NK) cell function. We compared the infectious complications in 116 recipients of a graft from a donor with an A/A KIR (n = 44) genotype and a B/x KIR (n = 72) genotype. All recipients participated in the prospective National Marrow Donor Program infection project collecting infection data from conditioning until 6 months posttransplant. The cohort with a B/x donor had fewer initial bacterial infections by day 180 (A/A: 86%; 95% confidence interval [CI], 75-95; B/x: 68%; 95% CI, 57-78; P = .02). There was no difference in the incidence of viral or fungal infections. When accounting for multiple infections, fewer bacterial infections were seen in the B/x cohort (A/A: 3.55/patient; B/x: 2.63/patient; P = .09). During the study period, only 19 patients had no infections; of these, 15 had received cells from a B/x KIR donor. The role of donor KIR genotype on infection complications is intriguing and warrants further investigation.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Mean number of infections during the first 180 days following HCT. The mean number of infections is shown as the infection density defined as the number of infections per patient per days at risk and normalized over the 180 study period.
Figure 2
Figure 2
The cumulative incidence of bacterial infections in recipients of a KIR A/A genotype and a KIR B/x genotype unrelated donor graft.
Figure 3
Figure 3
The adjusted relative infection density for a KIR A/A (dotted bar) donor recipient as compared to a KIR B/x (line) donor recipient during the first 180 days. A value above 1.0 indicates a higher mean ratio of infections in the KIR A/A cohort.
See this image and copyright information in PMC

References

    1. CIBMTR Summary Slides. 2009. http://www.cibmtr.org/SERVICES/summary_slides.html. 2009.
    1. Abi-Rached L, Parham P. Natural selection drives recurrent formation of activating killer cell immunoglobulin-like receptor and Ly49 from inhibitory homologues. The Journal of Experimental Medicine. 2005;201:1913–1932. - PMC - PubMed
    1. Uhrberg M, Valiante NM, Shum BP, et al. Human diversity in killer cell inhibitory receptor genes. Immunity. 1997;7:753–763. - PubMed
    1. Lu Z, Zhang B, Chen S, et al. Association of KIR genotypes and haplotypes with susceptibility to chronic hepatitis B virus infection in Chinese Han population. Cell Mol Immunol. 2008;5:457–463. - PMC - PubMed
    1. Genetics and the Immune Response. Tissue antigens; Abstracts of the 35th Annual Scientific Meeting of the Australasian Society for Immunology and the 14th International HLA and Immunogenetics Workshop; 4–8 Dec 2005; Melbourne, Australia. pp. 343–640. - PubMed

Publication types

MeSH terms